Guardian Pharmacy targets up to $974 mln valuation in US IPO
Adds background and details on results in paragraphs 4-11
Sept 16 (Reuters) -Guardian Pharmacy Services said on Monday it was targeting a valuation as much as $973.5 million in its initial public offering in the United States.
Expectations of an imminent interest rate cut by the U.S. Federal Reserve are encouraging more companies to press ahead with their listing plans.
Guardian Pharmacy is aiming to raise as much as $108 million by offering 6.75 million shares at a price range of $14 to $16 each.
Founded in 2004, the Atlanta-based company provides pharmacy services to long-term health care facilities in the United States. It owns 50 pharmacies and serves 174,000 residents across 36 states.
The company counts pharmacy services providers Omnicare, PharMerica, PharmCareUSA and Polaris Pharmacy Services among its competitors.
Guardian Pharmacy's revenue jumped to $575.4 million in the six months ended June 30, compared with $502.4 million in the same period in 2023.
More than two-thirds of Guardian Pharmacy's annual revenue over the past three years was from residents of assisted living facilities and behavioral health facilities and group homes, the company said.
The company earned $22.9 million in the first half of this year, compared with $30.2 million in the same period in 2023.
Guardian Pharmacy counts investment firms Bindley Capital Partners and Cardinal Equity Partners among its backers.
William Bindley serves as the chairman of Guardian Pharmacy. He was the founder and CEO of pharmaceutical distribution firm Bindley Western, which was acquired by Cardinal Health CAH.N in a $2.1 billion deal in 2001.
Guardian Pharmacy, which will use a portion of the IPO proceeds to lower debt, plans to list on the New York Stock Exchange under the symbol "GRDN".
Raymond James, Truist Securities and Stephens Inc are the underwriters for the offering.
Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Shounak Dasgupta
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
